As of a January 2026 legal analysis, BPC-157 remained listed in Category 2, and the compound cannot legally be compounded under sections 503A or 503B of the Food, Drug and Cosmetic Act
If you are pregnant, planning to become pregnant, or breastfeeding, this is vital to mention
Some patients see results within weeks
At Peak Performance Wellness & Aesthetics, we prescribe and manage GLP-1 weight loss medications with the kind of personalized, unhurried care you wont find at telehealth startups or franchise weight loss clinics
"For pharmaceutical executives, the lesson is clear: success in obesity will depend not only on science but also on vigilance, payer alignment, cultural reframing, and equitable access." But to understand this moment, it is important to trace the evolution of obesity drugs, why most failed, and what lessons the industry must carry forward